Carl Zeiss AG
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Carl Zeiss AG
Medtech Insight talked to GreyBird Ventures founder Tom Miller about his investment philosophy, ethical filter in selecting diagnostics-focused start-ups, the future of diagnostics such as at-home home-testing and AI, and his life-long passion for motocross racing.
In his recent report on Alcon, BTIG analyst Ryan Zimmerman estimated that its pharmaceutical portfolio could generate close to $900m in fiscal year 2022.
Swiss-based Vivior AG has developed a wearable Visual Behavior Monitor (VBM) designed to help surgical ophthalmologists determine the best treatment options for patients. The company's initial target is the $2.15bn global refractive and cataract surgery market.
Medtech M&A activity slowed in the last month of summer with just 16 mergers and acquisitions recorded on the Medtech Insight M&A Deal Tracker. However, the month included one billion-dollar deal and several deals in the ophthalmological sector.
- Medical Devices
- Other Names / Subsidiaries
- Carl Zeiss AG are: Carl Zeiss Meditec AG, Carl Zeiss Vision GmbH, Carl Zeiss SMT GmbH, Carl Zeiss IMT GmbH, Carl Zeiss Microscopy GmbH.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.